Paul Simms's guest appearances

Paul Simms

TV Take with Daniel Holloway

Relentless Health Value™

Faces of Digital Health

The Digitally Sick Podcast

The GOLD Podcast: Weekly Pharma Insights

Dispatches from Fort Awesome: A NewsRadio Podcast

Sound General Specifics

Shot of Digital Health Therapy

The Huxley Morton Podcast

Real World Talk with COTA

The Heap

The PEN Perspective Podcast

Storesome: Powering the Marketplace Platform Revolution (Conversations with eCommerce Leaders)

Eugene Borukhovich

Daniel Kraft

Michael Dillhyon

Julien de Salaberry

Shafi Ahmed

Rebecca Love

Seth Meyers

Brian Grazer

Bobbie Brown

Julia Roberts

Jessica Williams

Phoebe Robinson

Kurt Sutter

Damon Lindelof

Timothy Simons

OwlTail

Is it pharmageddon? Nope its just a Wednesday &amp; #TheShot of #DigitalHealth Therapy with Jim Joyce. Today we had pure enjoyment speaking with Paul Simms, who is a provocateur extraordinaire and have been in and around this industry for ~2 decades, so we had a lot to talk about:💊 Trust in pharma💊 Pharma business model💊 Misaligned objectives?💊 Is Pharma ready for #digitalhealth💊 Paul's 5D (watch to see what that is)💊 and.. whats on top of mind of Pharma CEO's💊 oh and... congrats to Jim Joyce &amp; HealthBeacon team for being in top 5 2021 IPO's in a CB Insights report!!Fun mentions as always: Eddie Martucci Marina Borukhovich Jessica J. Federer Steve Seuntjens Alyssa Jaffee

Is it pharmageddon? Nope its just a Wednesday &amp; <a href="https://www.linkedin.com/feed/hashtag/?keywords=theshot&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6892213099881910273" rel="nofollow" target="_blank">#TheShot</a> of <a href="https://www.linkedin.com/feed/hashtag/?keywords=digitalhealth&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6892213099881910273" rel="nofollow" target="_blank">#DigitalHealth</a> Therapy with <a href="https://www.linkedin.com/in/ACoAAAAP1xgBw9CHX2Lgrni5HBzYFjico01yVnc" rel="nofollow" target="_blank">Jim Joyce</a>. Today we had pure enjoyment speaking with <a href="https://www.linkedin.com/in/ACoAAAA1sFEBaPdV6S__AQhwg3hMDoz_PS7o0NY" rel="nofollow" target="_blank">Paul Simms</a>, who is a provocateur extraordinaire and have been in and around this industry for ~2 decades, so we had a lot to talk about: 💊 Trust in pharma💊 Pharma business model💊 Misaligned objectives?💊 Is Pharma ready for <a href="https://www.linkedin.com/feed/hashtag/?keywords=digitalhealth&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6892213099881910273" rel="nofollow" target="_blank">#digitalhealth</a>💊 Paul's 5D (watch to see what that is)💊 and.. whats on top of mind of Pharma CEO's💊 oh and... congrats to <a href="https://www.linkedin.com/in/ACoAAAAP1xgBw9CHX2Lgrni5HBzYFjico01yVnc" rel="nofollow" target="_blank">Jim Joyce</a> &amp; <a href="https://www.linkedin.com/company/healthbeacon/" rel="nofollow" target="_blank">HealthBeacon</a> team for being in top 5 2021 IPO's in a <a href="https://www.linkedin.com/company/cb-insights/" rel="nofollow" target="_blank">CB Insights</a> report!! Fun mentions as always: <a href="https://www.linkedin.com/in/ACoAAAIsNXIB8MgwPyuW1iWZeudlF92ETCScoXM" rel="nofollow" target="_blank">Eddie Martucci</a> <a href="https://www.linkedin.com/in/ACoAAACos6gBDyruFY6d8lPfcZW3q0tEku-j5ho" rel="nofollow" target="_blank">Marina Borukhovich</a> <a href="https://www.linkedin.com/in/ACoAAABOOH0BNBO0f089r4tWgykPKS-G9u7qGJc" rel="nofollow" target="_blank">Jessica J. Federer</a> <a href="https://www.linkedin.com/in/ACoAAAIJw0UBF8qA9oEiWzv5URSA_mg-hnGqmCY" rel="nofollow" target="_blank">Steve Seuntjens</a> <a href="https://www.linkedin.com/in/ACoAAAJ0FPwBNnVuLg_BWHDgwFFkdq1i0wDmvNQ" rel="nofollow" target="_blank">Alyssa Jaffee</a>

Shot of #DigitalHealth Therapy - Paul Simms

This week we hear from “Pharma Provocateur" and CEO of Impatient Health, Paul Simms. Paul set up Impatient health in May 2020 to challenge the Status Quo and help companies within the industry stand out from the crowd. He believes “now is the age of experimentation”. We hear how Paul is looking to drive Innovative conversations forward and isn’t afraid to break a few eggs in the process. Paul shares some thought-provoking views and his predictions for the future of Pharma. Click the link below to connect with Paul Simms https://www.linkedin.com/in/psimms/

This week we hear from “Pharma Provocateur" and CEO of Impatient Health, Paul Simms. Paul set up Impatient health in May 2020 to challenge the Status Quo and help companies within the industry stand out from the crowd. He believes “now is the age of experimentation”. We hear how Paul is looking to drive Innovative conversations forward and isn’t afraid to break a few eggs in the process. Paul shares some thought-provoking views and his predictions for the future of Pharma. Click the link below to connect with Paul Simms <a href="https://www.linkedin.com/in/psimms/" rel="nofollow" target="_blank">https://www.linkedin.com/in/psimms/</a>

Series 3 Episode 4- Paul Simms “Pharma Provocateur” and CEO of Impatient health.

This week, we are joined by Paul Simms, Chief Executive, Impatient Health and Pharma Provocateur, who shares his experience of the past year, the importance of overcoming red tape in pursuit of innovation, and his predictions for the pharmaceutical industry in 2021.

Talking to Paul Simms

In this episode of the Real World Talk podcast, Zoe Li talks to Paul Simms,  a Managing Partner at Inpatient Health.For 17 years, Paul was running a company called IFA pharma. As he says, it was helpful because it put him in touch with everybody in the industry and allowed him to understand the trends and the beliefs.Paul and Zoe discuss why the pharma industry is science-centric and not patient-centric. Paul also says if we want to understand the problem, we need to experience it. The guest mentions problems he sees in leadership and healthcare. As he explains, leaders usually talk about present or past actions, and no one talks about the future. He also notices the lack of imagination and creativity within the industry and, as a solution, offers the model of four A's: ambition, attention, accountability, and action. 

In this episode of the Real World Talk podcast, Zoe Li talks to Paul Simms, a Managing Partner at Inpatient Health.For 17 years, Paul was running a company called IFA pharma. As he says, it was helpful because it put him in touch with everybody in the industry and allowed him to understand the trends and the beliefs.Paul and Zoe discuss why the pharma industry is science-centric and not patient-centric. Paul also says if we want to understand the problem, we need to experience it. The guest mentions problems he sees in leadership and healthcare. As he explains, leaders usually talk about present or past actions, and no one talks about the future. He also notices the lack of imagination and creativity within the industry and, as a solution, offers the model of four A's: ambition, attention, accountability, and action.

Necessity is the Mother of Invention With Paul Simms

Bob Cohen

Bob joinsToronto songwriter, Steve-Paul Simms, on his never-before-released song, "Dancing Shoes".  With special guest: Keith Walton (tuba)Episode Producer: Zoe Henderson

Bob joinsToronto songwriter, Steve-Paul Simms, on his never-before-released song, "Dancing Shoes".  With special guest: Keith Walton (tuba) Episode Producer: Zoe Henderson

Steve-Paul Simms: More Music with Bob Cohen & Friends #4

In this episode, I’m joined by not one, but two guests from Adyen, the payments platform of choice for many of the world's leading companies. Joining me live from Adyen is Colin Neil, SVP of Business Development and Paul Simms, VP of Business Development. While we covered a lot of ground in this episode, the topic was guided around the growing importance of having a robust payment strategy from a business standpoint, with a view into the future and the trends that are breaking over the payments horizon. If you enjoyed this episode, be sure to like and share on social media, and if this conversation left you itching to learn more about the future of payments, you can reach out to Adyen directly at their website www.adyen.com. Learn more about Storesome and the marketplace solution we offer: https://www.storesome.com

In this episode, I’m joined by not one, but two guests from Adyen, the payments platform of choice for many of the world's leading companies. Joining me live from Adyen is Colin Neil, SVP of Business Development and Paul Simms, VP of Business Development. While we covered a lot of ground in this episode, the topic was guided around the growing importance of having a robust payment strategy from a business standpoint, with a view into the future and the trends that are breaking over the payments horizon. If you enjoyed this episode, be sure to like and share on social media, and if this conversation left you itching to learn more about the future of payments, you can reach out to Adyen directly at their website <a href="http://www.adyen.com/" rel="nofollow" target="_blank">www.adyen.com</a>. Learn more about Storesome and the marketplace solution we offer: <a href="https://www.storesome.com/" rel="nofollow" target="_blank">https://www.storesome.com</a>

Adyen: The Growing Importance of a Payments Strategy and What Does The Future Hold for Payments? (Colin Neil, SVP and Paul Simms, VP)

Welcome to the second episode of The Rise of the Customer Podcast, the go-to podcast for CX professionals looking to transform their organisation. Joining Neil in episode two is Paul Simms, the leading Pharma industry expert, known to many as the ‘Pharma Provocateur’ for his role in shaking up the industry. As an independent thought leader and advisor to many leading pharma players, Paul knows the challenges that the industry faces and is on a mission to  disrupt the status quo within the pharma industry. Something he regularly receives praise for from industry figures and commentators alike.With such a deep understanding of the Pharma Industry there was so much to discuss in this conversation and paul shared some really thought provoking and useful ideas across a range of topics including:➡️ What the rise of the customer means within the pharma industry and how it needs to adapt to meet the needs of new informed patients➡️ What changes fragmented healthcare models need to make to embrace the digital world➡️ Where most pharma businesses go wrong with innovation and why new innovation needs to sit in the commercial customer facing part of your organisation to be successful.With Covid-19 shining a bright spotlight on the pharma industry and creating challenges right across the value chain, now is the perfect time to be considering how to enhance your customer experience for competitive advantage. If you’re looking to understand how you can do this, then you’re definitely going to want to listen to this episode.

Welcome to the second episode of The Rise of the Customer Podcast, the go-to podcast for CX professionals looking to transform their organisation. Joining Neil in episode two is Paul Simms, the leading Pharma industry expert, known to many as the ‘Pharma Provocateur’ for his role in shaking up the industry. As an independent thought leader and advisor to many leading pharma players, Paul knows the challenges that the industry faces and is on a mission to disrupt the status quo within the pharma industry. Something he regularly receives praise for from industry figures and commentators alike. With such a deep understanding of the Pharma Industry there was so much to discuss in this conversation and paul shared some really thought provoking and useful ideas across a range of topics including: ➡️ What the rise of the customer means within the pharma industry and how it needs to adapt to meet the needs of new informed patients ➡️ What changes fragmented healthcare models need to make to embrace the digital world ➡️ Where most pharma businesses go wrong with innovation and why new innovation needs to sit in the commercial customer facing part of your organisation to be successful. With Covid-19 shining a bright spotlight on the pharma industry and creating challenges right across the value chain, now is the perfect time to be considering how to enhance your customer experience for competitive advantage. If you’re looking to understand how you can do this, then you’re definitely going to want to listen to this episode.

Rise Of The Customer - S1E2 – Paul Simms

Paul is the CEO and Founder of Eyeforpharma  - international hub connecting senior-level pharma executives, patient groups and other health stakeholders to exchange ideas and observe shifting trends and practices at events, in reports and conferences. In this second episode of a short series about digital therapeutics, Paul talks about the relationship between Pharma and DTx and Pharma development as an industry in general. As an Advisor to Hu-manity.co Paul also discussed the concept of people owning their data and managing it as property. Webinar about innovation financing in times of COVID-19: https://www.eventbrite.com/e/healthcare-innovation-financing-in-times-of-covid-19-tickets-101653044994 Recap of the show: www.facesofdigitalhealth.com/blog/f073-dtx-series-24-whats-pharma-got-to-do-with-digital-therapeutics-paul-simms

Paul is the CEO and Founder of Eyeforpharma  - international hub connecting senior-level pharma executives, patient groups and other health stakeholders to exchange ideas and observe shifting trends and practices at events, in reports and conferences. In this second episode of a short series about digital therapeutics, Paul talks about the relationship between Pharma and DTx and Pharma development as an industry in general. As an Advisor to <a href="http://Hu-manity.co" rel="nofollow" target="_blank">Hu-manity.co</a> Paul also discussed the concept of people owning their data and managing it as property.   Webinar about innovation financing in times of COVID-19: <a href="https://www.eventbrite.com/e/healthcare-innovation-financing-in-times-of-covid-19-tickets-101653044994" rel="nofollow" target="_blank">https://www.eventbrite.com/e/healthcare-innovation-financing-in-times-of-covid-19-tickets-101653044994</a>  Recap of the show: <a href="http://www.facesofdigitalhealth.com/blog/f073-dtx-series-24-whats-pharma-got-to-do-with-digital-therapeutics-paul-simms" rel="nofollow" target="_blank">www.facesofdigitalhealth.com/blog/f073-dtx-series-24-whats-pharma-got-to-do-with-digital-therapeutics-paul-simms</a>

F073 DTx series 2/5: What's Pharma got to do with digital therapeutics? (Paul Simms)

Across industries digital transformation is described as a radical rethinking of how organizations use technology, people and processes to fundamentally change and improve what they do. These changes are typically focussed on the development of new business models and revenue streams, driven predominantly by radical changes in customer expectations. Healthcare is one of the area’s most in need of a radical digital transformation as technology has completely revolutionised how we discover new drugs, diagnose disease, measure &amp; support chronic diseasea and its progression and how healthcare professionals expect to improve patient care and communicate with pharmaceutical companies.Paul Simms, Chairman of Eyeforpharma, joins the pod to discuss how pharma has approached the digital transformation of the industry  and how it could possibly be accelerated and improved.

Across industries digital transformation is described as a radical rethinking of how organizations use technology, people and processes to fundamentally change and improve what they do. These changes are typically focussed on the development of new business models and revenue streams, driven predominantly by radical changes in customer expectations. Healthcare is one of the area’s most in need of a radical digital transformation as technology has completely revolutionised how we discover new drugs, diagnose disease, measure &amp; support chronic diseasea and its progression and how healthcare professionals expect to improve patient care and communicate with pharmaceutical companies. Paul Simms, Chairman of Eyeforpharma, joins the pod to discuss how pharma has approached the digital transformation of the industry  and how it could possibly be accelerated and improved.

Talking digital transformation in Pharma with special guest Paul Simms 

This week, we meet The Creator again. (revisited)